Inositol 1,4,5-trisphosphate receptors are autoantibody target antigens in patients with Sjögren's syndrome and other systemic rheumatic diseases

References

• Fox RI. Sj8gren's syndrome. Lancet 2005;366:321–31.
   PubMed Web of Science ®Google Scholar
• Miyachi K, Naito M, Maeno Y, Suzuki S, Hamamoto T, Sugiura M, et al. Sialographic study in patients with and without antibodies to Sjögren's syndrome A(Ro). J Ftheumato11983;10:387–94.
   Google Scholar
• Tan EM. Antinuclear antibodies: diagnostic markers for autoim-mune diseases and probes for cell biology. Adv Immunol 1989;44: 93–151.
   PubMed Web of Science ®Google Scholar
• Tanahashi N, Yokota K, Alm JY, Chung CH, Fujiwara T, Taka-hashi E, et al. Molecular properties of the proteasome activator PA28 family proteins and gamma-interferon regulation. Genes Cells 1997;2: 195–211.
   Google Scholar
• Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, et al. Identification of a-Fodrin as a candidate autoantigen in primary Sjögren's syndrome Science 1997;276:604–7.
   Google Scholar
• Griffith KJ, Chan EK, Lung CC, Hamel JC, Guo X, Miyachi K, et al. Molecular cloning of a novel 97-kd Golgi complex autoanti-gen associated with Sjögren's syndrome. Arthritis Rheum 1997;40: 1693–702.
   PubMed Web of Science ®Google Scholar
• Selack S, Mahler M, Miyachi K, Fritzler ML, Fritzler MJ. Identifi-cation of the B-cell epitopes of the early endosome antigen (EEA1). Clin Immunol 2003; 109:154–64.
   Google Scholar
• Miyachi K, Hirano Y, Horigome T, Mimori T, Miyakawa H, Onozuka Y, et al. Autoantibodies from primary cirrhosis patients with anti-p95c antibodies bind to recombinant p97/VCP and inhibit in vitro nuclear envelope assembly. Chin Exp Immunol 2004;136: 568–73.
   PubMed Web of Science ®Google Scholar
• Futatsugi A, Nakamura T, Yamada MK, Ebisui E, Nakamura K, Uchida K, et al. IP,Receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science 2005;309:2232–34.
   PubMed Web of Science ®Google Scholar
• Vitali C, Moutsopoulos HM, Bombardieri S. The European community study group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis 1994;53: 637–47.
   Google Scholar
• Vitali C. Classification criteria for Sj8gren's syndrome Ann Rheum Dis 2003;62:94-5; author's reply 95.
   Google Scholar
• Smolen JS, Butcher B, Fritzler MJ, Gordon T, Hardin J, Kaldan JR, et al. Reference sera for antinuclear antibodies. Further defini-tion of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and immunoblotting. Arthritis Rheum 1997;40:413–8.
   Google Scholar
• Miyachi K, Matsushima H, Hankins RW, Hirakata M, Mimori T, Hosaka H, et al. A novel antibody directed against a three-dimensional configuration of a 95-kDa protein in patients with autoimmune hepatic diseases. Scand J Immunol 1998;136:568–73.
   Google Scholar
• Mimori T, Ohosone Y, Hama N, Suwa A, Akizuki M, Homma M, et al. Isolation and characterization of cDNA encoding the 80kD a subunit protein of the human autoantigen Ku(p70/p80) recognized by autoantibodies from patients with scleroderma poly-myositis overlap syndrome. Proc Nath Acad Sci USA 1990;87: 1777–81.
   PubMed Web of Science ®Google Scholar
• Miyachi K, Takano S, Mimori T, Yamagata H, Mita S, Matsuoka Y, et al. A novel autoantibody reactive with a 48 kDa tFtNA associ-ated protein in patients with scleroderma. J Ftheumatol 1991;18: 373–8.
   Google Scholar
• Matsumura M, Ohosone Y, Miyachi K, Akizuki M, Matsuoka Y, Irimajiri S, et al. Novel autoantibodies directed against the com-mon tertiary configuration of transfer RNA in a patient with inter-stitial lung disease. Arthritis Rheum 1996;44:877–82.
   Google Scholar
• Iwai M, Tateishi Y, Hattori M, Mizutani A, Nakamura T, Futatsugi A, et al. Molecular cloning of mouse type 2 and type 3 inositol tri-sphospate receptors and identification of a novel type 2 receptor splice variant. J Biol Chem 2005;280:10305–17.
   PubMedGoogle Scholar
• Ando H, Mizutani A, Matsuura T, Mikoshiba K. IRBIT. A novel inositol 1,4,5-trisphospate (IP,) receptor-binding protein, is re-leased from the IP3 receptor upon IP3 binding to the receptor. J Biol Chem 2003;278: 10602–12.
   Google Scholar
• Hattori M, Suzuki AZ, Higo T, Miyauchi H, Michikawa T, Naka-mura T, et al. Distinct roles of inositol 1,4,5-trisphosphate receptor types 1 and 3 in Ca2+ signaling. J Biol Chem. 2004;279: 11967–75.
   Google Scholar
• Furuichi T, Yoshikawa S, Miyawaki A, Wada K, Maeda N, Mikoshiba K. Primary structure and functional expression of the inositol 1,4,5 -trisphosphate-binding protein P400. Nature 1989;342:32–8.
   PubMed Web of Science ®Google Scholar
• Furuichi T, Mikoshiba K. Inositol 1,4,5-trisphosphate receptor- 25. mediated Ca2" signaling in the brain. J Neurochem 1995;64;953–60.26.
   Google Scholar
• Mikoshiba K. Inositol 1,4,5-trisphosphate (IP3) receptors and their role in neuronal cell function. J Neurochem 2006;97;1627–33.
   PubMedGoogle Scholar
• Zhang S, Malmersjo S, Li J, Ando H, Aizman 0, Uhlen P, et al. Distinct role of N-terminal tail of the Na-K-ATPase catalytic sub- unit as a signal transducer. J Biol Chem 2006;281:21954-61.27.
   Google Scholar
• Ogura T, Wilkinson AJ. AAA' superfamily ATPase: common structure — diverse function. Genes Cells 2001;6:575–97.
   PubMed Web of Science ®Google Scholar
• Woodman PG. p97, a protein coping with multiple identities. J Cell Sci 2003;116:4283–90.
   PubMed Web of Science ®Google Scholar
• Miyachi K, Hankins R, Ihara M, Miyamoto A, Okano T, Iwai M, et al. A case of limited cutaneous systemic sclerosis develop-ing anti-mitochondrial antibody positive primary biliary cirrhosis after acute myocardial infarction. Clin Ftheumatol 2006 Nov 25; [Epub ahead of print] PMID: 17131037
   Google Scholar
• Uchida K, Miyauchi H, Furuichi T, Michikawa T, Mikoshiba K. Critical regions for activation gating of the inositol 1,4,5-trisphosphate receptor J Biol Chem 2003;278: 16551–60.
   Google Scholar